Medtech industry association, COCIR, has called for a risk-based extension of the Medical Device Regulation grace period for legacy products. This relates to products that have notified body certificates granted in the context of the former medical device directives.
Although no details have been fleshed out by COCIR, this proposal sounds similar to the risk-based extension that has been granted under the IVD Regulation, where the riskier products have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?